Racial and ethnic differences in antiseizure medications among people with epilepsy on medicaid: a case of potential inequities
WP Bensken, G Fernandez Baca Vaca… - Neurology: Clinical …, 2023 - AAN Enterprises
Background and Objectives Being on a newer, second-, and third-generation antiseizure
medication (ASM) may represent an important marker of quality of care for people with …
medication (ASM) may represent an important marker of quality of care for people with …
Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid: A Case of Potential Inequities
WP Bensken, GFB Vaca, PM Alberti… - Neurology. Clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Background and objectives Being on a newer, second-, and third-generation antiseizure
medication (ASM) may represent an important marker of quality of care for people with …
medication (ASM) may represent an important marker of quality of care for people with …
Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid: A Case of Potential Inequities.
WP Bensken, PM Alberti, OI Khan… - Neurology. Clinical …, 2023 - europepmc.org
Methods Using Medicaid claims data, we identified the type and number of ASMs, as well as
the adherence, for people with epilepsy over a 5-year period (2010-2014). We used …
the adherence, for people with epilepsy over a 5-year period (2010-2014). We used …
[PDF][PDF] Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid
WP Bensken, GFB Vaca, PM Alberti… - Neurology: Clinical …, 2023 - academia.edu
Methods Using Medicaid claims data, we identified the type and number of ASMs, as well as
the adherence, for people with epilepsy over a 5-year period (2010–2014). We used …
the adherence, for people with epilepsy over a 5-year period (2010–2014). We used …
[HTML][HTML] Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid: A Case of Potential Inequities
WP Bensken, GFB Vaca, PM Alberti… - Neurology: Clinical …, 2023 - ncbi.nlm.nih.gov
Methods Using Medicaid claims data, we identified the type and number of ASMs, as well as
the adherence, for people with epilepsy over a 5-year period (2010–2014). We used …
the adherence, for people with epilepsy over a 5-year period (2010–2014). We used …
Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid: A Case of Potential Inequities.
WP Bensken, PM Alberti, OI Khan… - Neurology. Clinical …, 2023 - europepmc.org
Methods Using Medicaid claims data, we identified the type and number of ASMs, as well as
the adherence, for people with epilepsy over a 5-year period (2010-2014). We used …
the adherence, for people with epilepsy over a 5-year period (2010-2014). We used …